# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-22-027865
Filing Date
2022-08-02
Accepted
2022-08-02 17:25:40
Documents
3
Period of Report
2022-09-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | ny20004814x3_pre14a.htm | PRE 14A | 757009
2 |  | ny20004814x3-pc_1.jpg | GRAPHIC | 643077
3 |  | ny20004814x3-pc_2.jpg | GRAPHIC | 391926
| Complete submission text file | 0001140361-22-027865.txt |  | 2183058

Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-11460 | Film No.: 221129959
SIC: 2834 Pharmaceutical Preparations